Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018   94,465,440      
Beginning balance at Dec. 31, 2018 $ 320,443 $ 94 $ 340,291 $ (579) $ (19,363)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issuance ESPP Plan (in shares)   36,032      
Common stock issuance ESPP Plan 419   419    
Stock issuance fees and expenses (66)   (66)    
Gain (loss) on effective cash flow hedges (557)     (557)  
Issuance of restricted stock, net of forfeitures (in shares)   (182,502)      
Issuance of common stock for stock options (in shares)   619,536      
Issuance of common stock for stock options 3,894 $ 1 3,893    
ESPP expense 119   119    
Stock-based compensation expense - options and restricted stock 2,020   2,020    
NET (LOSS) INCOME (2,424)       (2,424)
Ending balance (in shares) at Mar. 31, 2019   95,303,510      
Ending balance at Mar. 31, 2019 323,848 $ 95 346,676 (1,136) (21,787)
Beginning balance (in shares) at Dec. 31, 2018   94,465,440      
Beginning balance at Dec. 31, 2018 320,443 $ 94 340,291 (579) (19,363)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Cash flow hedge termination reclassified to earnings 0        
NET (LOSS) INCOME (433)        
Ending balance (in shares) at Jun. 30, 2019   103,834,212      
Ending balance at Jun. 30, 2019 489,734 $ 104 511,589 (2,163) (19,796)
Beginning balance (in shares) at Mar. 31, 2019   95,303,510      
Beginning balance at Mar. 31, 2019 323,848 $ 95 346,676 (1,136) (21,787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issuance ESPP Plan (in shares)   37,255      
Common stock issuance ESPP Plan 653   653    
Stock issuance fees and expenses (211)   (211)    
Gain (loss) on effective cash flow hedges (1,027)     (1,027)  
Cash flow hedge termination reclassified to earnings 0        
Issuance of restricted stock, net of forfeitures (in shares)   (633)      
Working capital adjustment related to acquisition (in shares)   (99,524)      
Working capital adjustment related to acquisition (1,977)   (1,977)    
Issuance of common stock - Public Offering (in shares)   8,050,000      
Issuance of common stock - Public Offering 160,774 $ 8 160,766    
Issuance of common stock for stock options (in shares)   543,604      
Issuance of common stock for stock options 3,370 $ 1 3,369    
ESPP expense 162   162    
Stock-based compensation expense - options and restricted stock 2,151   2,151    
NET (LOSS) INCOME 1,991       1,991
Ending balance (in shares) at Jun. 30, 2019   103,834,212      
Ending balance at Jun. 30, 2019 489,734 $ 104 511,589 (2,163) (19,796)
Beginning balance (in shares) at Dec. 31, 2019   104,781,236      
Beginning balance at Dec. 31, 2019 507,408 $ 105 520,278 (1,618) (11,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issuance ESPP Plan (in shares)   34,330      
Common stock issuance ESPP Plan 796   796    
Stock issuance fees and expenses (15)   (15)    
Gain (loss) on effective cash flow hedges (1,038)     (1,038)  
Issuance of restricted stock, net of forfeitures (in shares)   (76,618)      
Issuance of restricted stock, net of forfeitures (212)   (212)    
Issuance of common stock for stock options (in shares)   503,873      
Issuance of common stock for stock options 2,897   2,897    
ESPP expense 194   194    
Stock-based compensation expense - options and restricted stock 1,991   1,991    
NET (LOSS) INCOME (6,978)       (6,978)
Ending balance (in shares) at Mar. 31, 2020   105,396,057      
Ending balance at Mar. 31, 2020 505,043 $ 105 525,929 (2,656) (18,335)
Beginning balance (in shares) at Dec. 31, 2019   104,781,236      
Beginning balance at Dec. 31, 2019 507,408 $ 105 520,278 (1,618) (11,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Cash flow hedge termination reclassified to earnings $ 2,661        
Issuance of common stock for stock options (in shares) 691,299        
NET (LOSS) INCOME $ (13,802)        
Ending balance (in shares) at Jun. 30, 2020   110,396,844      
Ending balance at Jun. 30, 2020 654,229 $ 110 679,235 43 (25,159)
Beginning balance (in shares) at Mar. 31, 2020   105,396,057      
Beginning balance at Mar. 31, 2020 505,043 $ 105 525,929 (2,656) (18,335)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issuance ESPP Plan (in shares)   41,058      
Common stock issuance ESPP Plan 928   928    
Stock issuance fees and expenses (317)   (317)    
Gain (loss) on effective cash flow hedges 38     38  
Cash flow hedge termination reclassified to earnings 2,661     2,661  
Issuance of restricted stock, net of forfeitures (in shares)   (24,786)      
Issuance of restricted stock, net of forfeitures (824)   (824)    
Issuance of common stock - Public Offering (in shares)   4,751,500      
Issuance of common stock - Public Offering 127,293 $ 5 127,288    
Issuance of common stock for stock options (in shares)   183,443      
Issuance of common stock for stock options 2,014   2,014    
ESPP expense 211   211    
Stock-based compensation expense - options and restricted stock 2,424   2,424    
Equity component of convertible note issuance 30,912   30,912    
Tax liability related to convertible note issuance (9,330)   (9,330)    
NET (LOSS) INCOME (6,824)       (6,824)
Ending balance (in shares) at Jun. 30, 2020   110,396,844      
Ending balance at Jun. 30, 2020 $ 654,229 $ 110 $ 679,235 $ 43 $ (25,159)